1. Neff M, Rubenfeld G: Clinical epidemiology of acute lung injury.
Semin Respir Crit Care Med 22:237, 2001.
[PubMed: 16088676]
2. Rubenfeld GD: Epidemiology of acute lung injury. Crit Care Med 31:S276, 2003.
3. ARDSnet Investigators. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301, 2000.
4. The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327, 2004.
5. Derdak S, Mehta S, Stewart TE, et al: Multicenter oscillatory ventilation for acute respiratory distress syndrome trial study I. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial [see comment].
Am J Respir Crit Care Med 166:801, 2002.
[PubMed: 12231488]
6. Anzueto A, Baughman RP, Guntupalli KK, et al: Aerosolized surfactant in adults with sepsis induced acute respiratory distress syndrome.
N Engl J Med 334:1417, 1996.
[PubMed: 8618579]
7. Amato MB, Barbas CS, Medeiros DM, et al: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.
N Engl J Med 338:347, 1998.
[PubMed: 9449727]
8. Brochard L, Roudot-Thoraval F, Roupie E, et al: Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trial Group on Tidal Volume Reduction in ARDS.
Am J Respir Crit Care Med 158:1831, 1998.
[PubMed: 9847275]
9. Stewart TE, Meade MO, Cook DJ, et al: Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group.
N Engl J Med 338:355, 1998.
[PubMed: 9449728]
10. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults.
Lancet 2:319, 1967.
[PubMed: 4143721]
11. Fowler AA, Hamman RF, Good JT, et al: Adult respiratory distress syndrome: risk with common predispositions.
Ann Intern Med 98:593, 1983.
[PubMed: 6846973]
12. Pepe PE, Potkin RT, Reus DH, et al: Clinical predictors of the adult respiratory distress syndrome.
Am J Surg 144:124, 1982.
[PubMed: 7091520]
13. Hudson LD, Milberg JA, Anardi D, Maunder RJ: Clinical risks for development of the acute respiratory distress syndrome.
Am J Respir Crit Care Med 151:293, 1995.
[PubMed: 7842182]
14. Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress syndrome.
Am Rev Respir Dis 138:720, 1988.
[PubMed: 3202424]
15. Sloane PJ, Gee MH, Gottlieb JE, et al: A multicenter registry of patients with acute respiratory distress syndrome.
Am Rev Respir Dis 146:419, 1992.
[PubMed: 1489134]
16. Bernard GR, Reines HD, Brigham KL, et al: The American European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trials coordination.
Am J Resp Crit Care Med 149:818, 1994.
[PubMed: 7509706]
17. Gilbert R, Keighley JF: The arterial-alveolar
oxygen tension ratio. An index of gas exchange applicable to varying inspired
oxygen concentrations.
Am Rev Respir Dis 109:142, 1974.
[PubMed: 4809154]
18. Rubenfeld GD, Caldwell ES, Granton J, et al: Interobserver variability in applying a radiographic definition of ARDS.
Chest 116:1347, 1999.
[PubMed: 10559098]
19. Meade MO, Cook RJ, Guyatt GH, et al: Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome.
Am J Resp Crit Care Med 161:85, 2000.
[PubMed: 10619802]
20. Ferguson ND, Kacmarek RM, Chiche JD, et al: Screening of ARDS patients using standardized ventilator settings: influence on enrollment in a clinical trial.
Intensive Care Med 30:1111, 2004.
[PubMed: 14991096]
21. Ferguson ND, Meade MO, Hallett DC, Stewart TE: High values of the pulmonary artery wedge pressure in patients with acute lung injury and acute respiratory distress syndrome.
Intensive Care Med 28:1073, 2002.
[PubMed: 12185427]
22. Bindels AJ, van der Hoeven JG, Meinders AE: Pulmonary artery wedge pressure and extravascular lung water in patients with acute cardiogenic pulmonary edema requiring mechanical ventilation.
Am J Cardiol 84:1158, 1999.
[PubMed: 10569323]
23. Matthay MA, Zimmerman GA, Esmon C, et al: Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.
Am J Respir Crit Care Med 167:1027, 2003.
[PubMed: 12663342]
24. Goss CH, Brower RG, Hudson LD, Rubenfeld GD: Incidence of acute lung injury in the United States [comment].
Crit Care Med 31:1607, 2003.
[PubMed: 12794394]
25. Herridge MS, Cheung AM, Tansey CM, et al: Canadian Critical Care Trials G. One-year outcomes in survivors of the acute respiratory distress syndrome [comment].
N Engl J Med 348:683, 2003.
[PubMed: 12594312]
26. Angus DC, Musthafa AA, Clermont G, et al: Quality-adjusted survival in the first year after the acute respiratory distress syndrome.
Am J Respir Crit Care Med 163:1389, 2001.
[PubMed: 11371406]
27. Davidson T, Caldwell E, Curtis J, et al: Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
JAMA 281:354, 1999.
[PubMed: 9929089]
28. Davidson T, Rubenfeld G, Caldwell E, et al: The effect of acute respiratory distress syndrome on long-term survival.
Am J Respir Crit Care Med 160:1838, 1999.
[PubMed: 10588594]
29. Lewandowski K, Metz J, Deutschmann C, et al: Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany.
Am J Respir Crit Care Med 151:1121, 1995.
[PubMed: 7697241]
30. Neff MJ: The epidemiology and definition of the acute respiratory distress syndrome.
Respir Care Clin North Am 9:273, 2003.
[PubMed: 14690066]
31. Gattinoni L, Pelosi P, Suter PM, et al: Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?
Am J Respir Crit Care Med 158:3, 1998.
[PubMed: 9655699]
32. Pelosi P, Gattinoni L: Acute respiratory distress syndrome of pulmonary and extra-pulmonary origin: fancy or reality?
Intensive Care Med 27:457, 2001.
[PubMed: 11355111]
33. Gunther A, Walmrath D, Grimminger F, Seeger W: Pathophysiology of acute lung injury.
Semin Respir Crit Care Med 22:247, 2001.
[PubMed: 16088677]
34. Steinberg KP, Hudson LD: Acute lung injury and acute respiratory distress syndrome. The clinical syndrome.
Clin Chest Med 21:401, 2000.
[PubMed: 11019717]
35. Moss M, Parsons PE, Steinberg KP, et al: Chronic
alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock.
Crit Care Med 31:869, 2003.
[PubMed: 12626999]
36. Ware LB, Matthay MA: The acute respiratory distress syndrome.
N Engl J Med 342:1334, 2000.
[PubMed: 10793167]
37. Parsons P: Mediators and mechanisms of acute lung injury.
Clin Chest Med 21:467, 2000.
[PubMed: 11019720]
38. Moss M, Bucher B, Moore FA: The role of chronic
alcohol abuse in the development of acute respiratory distress syndrome in adults.
JAMA 275:50, 1996.
[PubMed: 8531287]
39. Moss M, Guidot DM, Steinberg KP, et al: Diabetic patients have a decreased incidence of acute respiratory distress syndrome.
Crit Care Med 28:2187, 2000.
[PubMed: 10921539]
40. Mangialardi RJ, Martin GS, Bernard GR, et al: Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis.
Ibuprofen in Sepsis Study Group.
Crit Care Med 28:3137, 2000.
[PubMed: 11008971]
41. Iribarren C, Jacobs DR Jr, Sidney S, et al: Cigarette smoking,
alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting.
Chest 117:163, 2000.
[PubMed: 10631215]
42. Moss M, Mannino DM: Race and gender differences in acute respiratory distress syndrome in the United States: an analysis of multiple-cause mortality data (1979–1996).
Crit Care Med 30:1679, 2002.
[PubMed: 12163776]
43. Suchyta MR, Clemmer TP, Elliott CG, et al: Increased mortality of older patients with acute respiratory distress syndrome.
Chest 111: 1334, 1997.
[PubMed: 9149591]
44. Doyle RL, Szaflarski N, Modin GW, et al: Identification of patients with acute lung injury. Predictors of mortality.
Am J Respir Crit Care Med 152:1818, 1995.
[PubMed: 8520742]
45. Monchi M, Bellenfant F, Cariou A, et al: Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis.
Am J Respir Crit Care Med 158:1076, 1998.
[PubMed: 9769263]
46. Luhr OR, Antonsen K, Karlsson M, et al: Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group.
Am J Respir Crit Care Med 159:1849, 1999.
[PubMed: 10351930]
47. Zilberger MD, Epstein SK: Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med 157:1159, 1998.
48. Lanken PN, Ancukiewicz M, Christie JD, et al: Baseline risk factors for mortality in 902 subjects with acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med 169:A18, 2004.
49. Nuckton TJ, Alonso JA, Kallet RH, et al: Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome.
N Engl J Med 346:1281, 2002.
[PubMed: 11973365]
50. Pelosi P, Gattinoni L: Acute respiratory distress syndrome of pulmonary and extra-pulmonary origin: fancy or reality?
Intensive Care Med 27:457, 2001.
[PubMed: 11355111]
51. Gattinoni L, Pelosi P, Suter PM: Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?
Am J Respir Crit Care Med 158:3, 1998.
[PubMed: 9655699]
52. Eisner MD, Thompson T, Hudson LD, et al: Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome.
Am J Respir Crit Care Med 164:231, 2001.
[PubMed: 11463593]
53. Montgomery AB, Stager MA, Carrico CJ, et al: Causes of mortality in patients with the adult respiratory distress syndrome.
Am J Respir Crit Care Med 132:485, 1985.
[PubMed: 4037521]
54. Bell RC, Coalson JJ, Smith JD, et al: Multiple organ system failure and infection in adult respiratory distress syndrome.
Ann Intern Med 99:293, 1983.
[PubMed: 6614678]
55. Tomashefski JF: Pulmonary pathology of acute respiratory distress syndrome.
Clin Chest Med 21:435, 2000.
[PubMed: 11019719]
56. Tomashefski JF Jr: Pulmonary pathology of the acute respiratory distress syndrome. Diffuse alveolar damage, in Ma M (ed): Acute Respiratory Distress Syndrome. New York, Marcel Dekker, 2003, p 75.
57. Meduri GU, Belenchia JM, Estes RJ, et al: Fibroproliferative phase of ARDS: Clinical findings and effects of corticosteroids.
Chest 100:943, 1991.
[PubMed: 1914609]
58. Pittet JF, Mackersie RC, Martin TR, Matthay MA: Biological markers of acute lung injury: prognostic and pathogenetic significance.
Am J Respir Crit Care Med 155:1187, 1997.
[PubMed: 9105054]
59. Clark JG, Milberg JA, Steinberg KP, Hudson LD: Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death [see comments].
Ann Intern Med 122:17, 1995.
[PubMed: 7985891]
60. Tracey KJ, Lowry SF, Cerami A: Cachetin/TNF-alpha in septic shock and septic adult respiratory distress syndrome.
Am Rev Respir Dis 138:1377, 1988.
[PubMed: 3059894]
61. Goodman RB, Strieter RM, Martin DP, et al: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome.
Am J Respir Crit Care Med 154:602, 1996.
[PubMed: 8810593]
62. Ghezzi P, Dinarello CA, Bianchi M, et al: Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells.
Cytokine 3:189, 1991.
[PubMed: 1883957]
64. Li XY, Donaldson K, Brown D, MacNee W: The role of tumor necrosis factor in increased airspace epithelial permeability in acute lung inflammation.
Am J Respir Cell Mol Biol 13:185, 1995.
[PubMed: 7626286]
65. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
Nature 330:662, 1987.
[PubMed: 3317066]
66. Beutler B, Cerami A: Cachectin: more than a tumor necrosis factor. N Engl J Med 316:380, 1987.
67. Gamble JR, Harlan JM, Klebonoff SJ, Vados MA: Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.
Proc Natl Acad Sci U S A 82:8667, 1985.
[PubMed: 3866246]
68. Pohlman TH, Stanness KA, Beatty PG, et al: An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism.
J Immunol 136:4548, 1986.
[PubMed: 3486903]
69. Bevilacqua MP, Pober JS, Wheeler ME, et al: Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion.
Am J Pathol 121:394, 1985.
[PubMed: 3878084]
70. Bevilacqua MP, Pober JS, Wheeler ME, et al: Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.
J Clin Invest 76:2003, 1985.
[PubMed: 3877078]
71. Bauer TT, Monton C, Torres A, et al: Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls.
Thorax 55:46, 2000.
[PubMed: 10607801]
72. Parsons PE, Moore FA, Moore EE, et al: Studies on the role of tumor necrosis factor in adult respiratory distress syndrome.
Am Rev Respir Dis 146:694, 1992.
[PubMed: 1519850]
73. Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA: Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome.
Am Rev Respir Dis 144:268, 1991.
[PubMed: 1859048]
74. Millar AB, Foley NM, Singer M, et al: Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome.
Lancet 2:712, 1989.
[PubMed: 2570960]
75. Suter PM, Suter S, Girardin E, et al: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis.
Am Rev Respir Dis 145:1016, 1992.
[PubMed: 1586041]
76. Pugin J, Ricou B, Steinberg KP, et al: Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1.
Am J Respir Crit Care Med 153:1850, 1996.
[PubMed: 8665045]
77. Park WY, Goodman RB, Steinberg KP, et al: Cytokine balance in the lungs of patients with acute respiratory distress syndrome.
Am J Respir Crit Care Med 164:1896, 2001.
[PubMed: 11734443]
78. Meduri GU, Headley S, Kohler G, et al: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time.
Chest 107:1062, 1995.
[PubMed: 7705118]
79. Schutte H, Lohmeyer J, Rosseau S, et al: Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema.
Eur Respir J 9:1858, 1996.
[PubMed: 8880103]
80. Martin TR: Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest 116:2S, 1999.
81. Xing Z, Gauldie J, Cox G, et al: IL-6 is an antiinflammatory cytokine required for controlling local or systemic inflammatory responses.
J Clin Invest 101:311, 1998.
[PubMed: 9435302]
82. Ranieri VM, Suter PM, Tortorella C, et al: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A Randomized Controlled Trial.
JAMA 282:54, 1999.
[PubMed: 10404912]
83. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor.
Annu Rev Immunol 19:683, 2001.
[PubMed: 11244051]
84. Armstrong L, Millar AB: Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome.
Thorax 52:442, 1997.
[PubMed: 9176536]
85. Parsons PE, Moss M, Vannice JL, et al: Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients.
Am J Respir Crit Care Med 155:1469, 1997.
[PubMed: 9105096]
86. Donnelly SC, Strieter RM, Reid PT, et al: The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome.
Ann Intern Med 125:191, 1996.
[PubMed: 8686976]
87. Sekido N, Mukaida N, Harada A, et al: Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8.
Nature 365:654, 1993.
[PubMed: 8413628]
88. Yokoi K, Mukaida N, Harada A, et al: Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8.
Lab Invest 76:375, 1997.
[PubMed: 9121120]
89. Matsumoto T, Yokoi K, Mukaida N, et al: Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury.
J Leukoc Biol 62:581, 1997.
[PubMed: 9365112]
90. Torre D, Zeroli C, Giola M, et al: Levels of interleukin-8 in patients with adult respiratory distress syndrome.
J Infect Dis 167:505, 1993.
[PubMed: 8421196]
91. Villard J, Dayer-Pastore F, Hamacher J, et al: GRO alpha and interleukin-8 in
Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome.
Am J Respir Crit Care Med 152:1549, 1995.
[PubMed: 7582292]
92. Miller EJ, Cohen AB, Nagao S, et al: Elevated levels of NAP-1/ interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality.
Am Rev Respir Dis 146:427, 1992.
[PubMed: 1489135]
93. Abraham E: Neutrophils and acute lung injury. Crit Care Med 31:S195, 2003.
94. Bachofen M, Weibel ER: Structural alterations of lung parenchyma in the adult respiratory distress syndrome.
Clin Chest Med 3:35, 1982.
[PubMed: 7075161]
95. Steinberg KP, Milberg JA, Martin TR, et al: Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome.
Am J Respir Crit Care Med 150:113, 1994.
[PubMed: 8025736]
96. Baughman RP, Gunther KL, Rashkin MC, et al: Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators.
Am J Respir Crit Care Med 154:76, 1996.
[PubMed: 8680703]
97. Matute-Bello G, Liles WC, Radella F 2nd, et al: Neutrophil apoptosis in the acute respiratory distress syndrome.
Am J Respir Crit Care Med 156:1969, 1997.
[PubMed: 9412582]
98. Matute-Bello G, Liles WC, Radella F 2nd, et al: Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome [see comment]. Crit Care Med 28:253, 2000.
99. Lesur O, Kokis A, Hermans C, et al: Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival.
Crit Care Med 28:3814, 2000.
[PubMed: 11153619]
100. Goodman ER, Stricker P, Velavicius M, et al: Role of granulocyte-macrophage colony-stimulating factor and its receptor in the genesis of acute respiratory distress syndrome through an effect on neutrophil apoptosis.
Arch Surg 134:1049, 1999.
[PubMed: 10522844]
101. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424, 1996.
102. Weiss SJ: Tissue destruction by neutrophils.
N Engl J Med 320:365, 1989.
[PubMed: 2536474]
103. Buhl R, Meyer A, Vogelmeier C: Oxidant-protease interaction in the lung. Prospects for antioxidant therapy. Chest 1996.110:267S–272S.
104. Gadek JE, Pacht ER: The interdependence of lung antioxidants and antiprotease defense in ARDS. Chest 110:273S, 1996.
105. Eiserich JP, Hristova M, Cross CE, et al: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils.
Nature 391:393, 1998.
[PubMed: 9450756]
106. Gutteridge JM, Quinlan GJ, Mumby S, et al: Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins.
J Lab Clin Med 124:263, 1994.
[PubMed: 8051491]
107. Kooy NW, Royall JA, Ye YZ, et al: Evidence for in vivo peroxynitrite production in human acute lung injury.
Am J Respir Crit Care Med 151:1250, 1995.
[PubMed: 7697261]
108. Ischiropoulos H, al-Mehdi AB: Peroxynitrite-mediated oxidative protein modifications.
FEBS Lett 364:279, 1995.
[PubMed: 7758583]
109. Ischiropoulos H, al-Mehdi AB, Fisher AB: Reactive species in ischemic rat lung injury: contribution of peroxynitrite. Am J Physiol 269:L158, 1995.
110. Zimmerman GA, Renzetti AD, Hill HR: Functional and metabolic activity of granulocytes from patients with the adult respiratory distress syndrome: evidence for activated neutrophils in the pulmonary circulation.
Am Rev Resp Dis 127:290, 1983.
[PubMed: 6830052]
111. Fisher AB, Dodia C, Tan Z, et al: Oxygen-dependent lipid peroxidation during lung ischemia.
J Clin Invest 88:674, 1991.
[PubMed: 1864976]
112. Fisher PW, Huang YC, Kennedy TP: PO2-dependent hydroxyl radical production during ischemia-reperfusion lung injury. Am J Physiol 265:L279, 1993.
113. Baldwin SR, Simon RH, Grum CM: Oxidant activity in expired breath of patients with adult respiratory distress syndrome.
Lancet 1:11, 1986.
[PubMed: 2867261]
114. Sznajder JI, Fraiman A, Hall JB, et al: Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure.
Chest 96:606, 1989.
[PubMed: 2766820]
115. Pacht ER, Timerman AP, Lykens MG, Merola AJ: Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome.
Chest 100:1397, 1991.
[PubMed: 1935300]
116. Bunnell E, Pacht ER: Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome.
Am Rev Respir Dis 148:1174, 1993.
[PubMed: 8239150]
117. Lamb NJ, Gutteridge JM, Baker C, et al: Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination.
Crit Care Med 27:1738, 1999.
[PubMed: 10507592]
118. Richard C, Lemonnier F, Thibault M, et al: Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome.
Crit Care Med 18:4, 1990.
[PubMed: 2293967]
119. Quinlan GJ, Evans TW, Gutteridge JM: 4-hydroxy-2-nonenal levels increase in the plasma of patients with adult respiratory distress syndrome as linoleic acid appears to fall.
Free Radic Res 21:95, 1994.
[PubMed: 7921168]
120. Quinlan GJ, Evans TW, Gutteridge JM: Oxidative damage to plasma proteins in adult respiratory distress syndrome.
Free Radic Res 20:289, 1994.
[PubMed: 8069386]
121. Quinlan GJ, Lamb NJ, Tilley R, et al: Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality.
Am J Respir Crit Care Med 155:479, 1997.
[PubMed: 9032182]
122. Gole MD, Souza JM, Choi I, et al: Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 278:L961, 2000.
123. Connelly KG, Moss M, Parsons PE, et al: Serum ferritin as a predictor of the acute respiratory distress syndrome.
Am J Respir Crit Care Med 155:21, 1997.
[PubMed: 9001283]
124. Sharkey RA, Donnelly SC, Connelly KG, et al: Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome.
Am J Respir Crit Care Med 159:1506, 1999.
[PubMed: 10228118]
125. Quinlan GJ, Evans TW, Gutteridge JM: Linoleic acid and protein thiol changes suggestive of oxidative damage in the plasma of patients with adult respiratory distress syndrome.
Free Radic Res 20:299, 1994.
[PubMed: 8069387]
126. Mathru M, Rooney MW, Dries DJ, et al: Urine hydrogen peroxide during adult respiratory distress syndrome in patients with and without sepsis.
Chest 105:232, 1994.
[PubMed: 8275738]
127. McDonald JA: The yin and yang of fibrin in the airways [comment].
N Engl J Med 322:929, 1990.
[PubMed: 2314427]
128. Idell S: Extravascular coagulation and fibrin deposition in acute lung injury.
New Horiz 2:566, 1994.
[PubMed: 7804805]
129. Abraham E: Coagulation abnormalities in acute lung injury and sepsis.
Am J Respir Cell Mol Biol 22:401, 2000.
[PubMed: 10745020]
130. Fuchs-Buder T, de Moerloose P, Ricou B, et al: Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. Am J Respir Crit Care Med 1:163, 1996.
131. Idell S, James KK, Levin EG, et al: Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.
J Clin Invest 84:695, 1989.
[PubMed: 2788176]
132. Idell S: Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 31:S213, 2003.
133. Idell S, Gonzalez K, Bradford H, et al: Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII.
Am Rev Respir Dis 136:1466, 1987.
[PubMed: 3688650]
134. Bevilacqua MP, Pober JS, Majeau GR, et al: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
Proc Natl Acad Sci U S A 83:4533, 1986.
[PubMed: 3487091]
135. Clouse LH, Comp PC: The regulation of hemostasis: the protein C system. [review].
N Engl J Med 314:1298, 1986.
[PubMed: 3010107]
136. Esmon CT: The regulation of natural anticoagulant pathways.
Science 235:1348, 1987.
[PubMed: 3029867]
137. Bernard GR, Vincent JL, Laterre PF, et al: Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis [comment].
N Engl J Med 344:699, 2001.
[PubMed: 11236773]
138. Ely EW, Laterre PF, Angus DC, et al: Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis [see comment].
Crit Care Med 31:12, 2003.
[PubMed: 12544987]
139. Matthay MA, Folkesson HG, Clerici C: Lung epithelial fluid transport and the resolution of pulmonary edema [review].
Physiol Rev 82:569, 2002.
[PubMed: 12087129]
140. Sakuma T, Okaniwa G, Nakada T, et al: Alveolar fluid clearance in the resected human lung [see comment].
Am J Respir Crit Care Med 150:305, 1994.
[PubMed: 8049807]
141. Sakuma T, Folkesson HG, Suzuki S, et al: Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs.
Am J Respir Crit Care Med 155:506, 1997.
[PubMed: 9032186]
142. Fang X, Fukuda N, Barbry P, et al: Novel role for CFTR in fluid absorption from the distal airspaces of the lung.
J Gen Physiol 119:199, 2002.
[PubMed: 11815669]
143. Suzuki S, Noda M, Sugita M, et al: Impairment of transalveolar fluid transport and lung Na(+)-K(+)-ATPase function by hypoxia in rats.
J Appl Physiol 87:962, 1999.
[PubMed: 10484564]
144. Vivona ML, Matthay M, Chabaud MB, et al: Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by beta-adrenergic agonist treatment.
Am J Respir Cell Mol Biol 25:554, 2001.
[PubMed: 11713096]
145. Hu P, Ischiropoulos H, Beckman JS, Matalon S: Peroxynitrite inhibition of
oxygen consumption and sodium transport in alveolar type II cells.
Am J Physiol 266:L628, 1994.
146. Verghese GM, Ware LB, Matthay BA, Matthay MA: Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema.
J Appl Physiol 87:1301, 1999.
[PubMed: 10517756]
147. Ware LB, Matthay MA: Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome [see comment].
Am J Respir Crit Care Med 163:1376, 2001.
[PubMed: 11371404]
148. Matthay MA, Wiener-Kronish JP: Intact epithelial barrier function is critical for the resolution of alveolar edema in humans [see comment].
Am Rev Respir Dis 142:1250, 1990.
[PubMed: 2252240]
149. Clark JG, Milberg JA, Steinberg KP, Hudson LD: Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death [see comments].
Ann Intern Med 122:17, 1995.
[PubMed: 7985891]
150. Marshall RP, Bellingan G, Webb S, et al: Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome.
Am J Respir Crit Care Med 162:1783, 2000.
[PubMed: 11069813]
151. Clark JG, Milberg JA, Steinberg KP, Hudson LD: Elevated lavage levels of N-terminal peptide of type III procollagen are associated with increased fatality in adult respiratory distress syndrome. Chest 3:126S, 1994.
152. Toews GB: Cellular alterations in fibroproliferative lung disease [Review]. Chest 116:112S, 1999.
153. Zhu HJ, Burgess AW: Regulation of transforming growth factor-beta signaling. [Review].
Mol Cell Biol Res Commun 4:321, 2001.
[PubMed: 11703090]
154. Madtes DK, Rubenfeld G, Klima LD, et al: Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome.
Am J Respir Crit Care Med 158:424, 1998.
[PubMed: 9700116]
155. Woods A: Syndecans: transmembrane modulators of adhesion and matrix assembly.
J Clin Invest 107:935, 2001.
[PubMed: 11306594]
156. Bensadoun ES, Burke AK, Hogg JC, Roberts CR: Proteoglycan deposition in pulmonary fibrosis.
Am J Respir Crit Care Med 154:1819, 1996.
[PubMed: 8970376]
157. Savani RC, Hou G, Liu P, et al: A role for hyaluronan in macrophage accumulation and
collagen deposition after bleomycin-induced lung injury.
Am J Respir Cell Mol Biol 23:475, 2000.
[PubMed: 11017912]
158. Bornstein P: Thrombospondins as matricellular modulators of cell function.
J Clin Invest 107:929, 2001.
[PubMed: 11306593]
159. Murphy-Ullrich JE: The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?[see comment] [Review] [36 refs].
J Clin Invest 107:785, 2001.
[PubMed: 11285293]
160. Shapiro SD, Senior RM: Matrix metalloproteinases. Matrix degradation and more.
Am J Respir Cell Mol Biol 20:1100, 1999.
[PubMed: 10340927]
161. Aberman A FM: The metabolic and respiratory acidosis of acute pulmonary edema.
Ann Intern Med 76:173, 1972.
[PubMed: 5009588]
162. Aberle DR, Brown K: Radiologic considerations in the adult respiratory distress syndrome.
Clin Chest Med 11:737, 1990.
[PubMed: 2268999]
163. Aberle DR, Wiener-Kronish, J, Webb WR, et al: Hydrostatic versus increased permeability pulmonary edema: Diagnosis based on radiographic criteria in critically ill patients.
Radiology 168:73, 1988.
[PubMed: 3380985]
164. Kaul S, Stratienko SA, Pollock SG, et al: Value of two-dimensional echocardiography for determining the basis of hemodynamic compromise in critically ill patients: A prospective study.
J Am Soc Echocardiol 7:598, 1994.
[PubMed: 7840987]
165. Foster E, Schiller NB: Transesophageal echocardiography in the critical care patient.
Cardiol Clin 11:489, 1993.
[PubMed: 8402776]
166. Fein AM, Goldberg SK, Walkenstein MD, et al: Is pulmonary artery catheterization necessary for the diagnosis of pulmonary edema?
Am J Respir Crit Care Med 129:1006, 1984.
[PubMed: 6732038]
167. Matthay MA, Chatterjee K: Bedside catheterization of the pulmonary artery: Risks compared with benefits.
Ann Intern Med 109:826, 1988.
[PubMed: 3056159]
168. Dalen JE, Bone RC: Is it time to pull the pulmonary artery catheter?
JAMA 276:916, 1996.
[PubMed: 8782643]
169. Connors AF, Speroff T, Dawson NV, et al: The effectiveness of right heart catheterization in the initial care of critically ill patients.
JAMA 276:889, 1996.
[PubMed: 8782638]
170. Robin ED: The cult of the Swan-Ganz catheter: Overuse and abuse of pulmonary flow catheters.
Ann Intern Med 103:445, 1985.
[PubMed: 3896088]
171. Iberti TJ, Fischer EP, Leibowitz AB, et al: A multicenter study of physicians' knowledge of the pulmonary artery catheter.
JAMA 264:2928, 1990.
[PubMed: 2232089]
172. McHugh TJ, Forrester JS, Adler L, et al: Pulmonary vascular congestion in acute myocardial infarction: hemodynamic and radiologic correlations.
Ann Intern Med 76:29–33, 1972.
[PubMed: 5021552]
173. Sibbald WJ, Cunningham DR, Chin DN: Non-cardiac or cardiac pulmonary edema? A practical approach to clinical differentiation in critically ill patients.
Chest 84:452, 1983.
[PubMed: 6617283]
174. Hogan TF, Riley RS, Thomas JG: Rapid diagnosis of acute eosinophilic pneumonia (AEP) in a patient with respiratory failure using bronchoalveolar lavage (BAL) with calcofluor white (CW) staining.
J Clin Lab Anal 11:202, 1997.
[PubMed: 9219061]
175. Pope-Harman AL, Davis WB, Allen ED, et al: Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature.
Medicine 75:334, 1996.
[PubMed: 8982150]
176. Allen JN, Davis WB: Eosinophilic lung diseases.
Am J Respir Crit Care Med 150:1423, 1994.
[PubMed: 7952571]
177. Steinberg KP, Mitchell DR, Maunder RJ, et al: Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome.
Am Rev Respir Dis 148:556, 1993.
[PubMed: 8368623]
178. Trouillet JL, Guiguet M, Gibert C, et al: Fiberoptic bronchoscopy in ventilated patients. Evaluation of cardiopulmonary risk under
midazolam sedation.
Chest 97:927, 1990.
[PubMed: 2108848]
179. Yen KT, Lee AS, Krowka MJ, Burger CD: Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment.
Clin Chest Med 25:189, 2004.
[PubMed: 15062610]
180. Afessa B, Tefferi A, Litzow MR, et al: Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients.
Am J Respir Crit Care Med 166:641, 2002.
[PubMed: 12204858]
181. Schwarz MI, Fontenot AP, Afessa B, et al: Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis.
Clin Chest Med 25:133, 2004.
[PubMed: 15062605]
182. Bar J, Ehrenfeld M, Rozenman J, et al: Pulmonary-renal syndrome in systemic sclerosis.
Semin Arthritis Rheum 30:403, 2001.
[PubMed: 11404823]
183. Lee JG, Joo KW, Chung WK, et al: Diffuse alveolar hemorrhage in lupus nephritis.
Clin Nephrol 55:282, 2001.
[PubMed: 11334313]
184. Specks U: Diffuse alveolar hemorrhage syndromes.
Curr Opin Rheumatol 13:12, 2001.
[PubMed: 11148710]
185. Franks TJ, Koss MN: Pulmonary capillaritis.
Curr Opin Pulm Med 6:430, 2000.
[PubMed: 10958235]
186. Green RJ, Ruoss SJ, Kraft SA, et al: Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management.
Chest 110:1305, 1996.
[PubMed: 8915239]
187. Gattinoni L, Caironi P, Pelosi P, Goodman LR: What has computed tomography taught us about the acute respiratory distress syndrome? [Review]
Am J Respir Crit Care Med 164:1701, 2001.
[PubMed: 11719313]
188. Gattinoni L, Pesenti A, Bombino M, et al: Relationships between lung computed tomographic density, gas exchange and PEEP in acute respiratory failure.
Anesthesiology 69:824, 1988.
[PubMed: 3057937]
189. Pare PD, Warriner B, Baile EM, Hogg JC: Redistribution of pulmonary extravascular water with positive end-expiratory pressure in canine pulmonary edema.
Am J Respir Crit Care Med 127:590, 1983.
[PubMed: 6342480]
190. Hilbert G, Gruson D, Vargas F, et al: Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure.
N Engl J Med 344:481, 2001.
[PubMed: 11172189]
191. Antonelli M, Conti G, Rocco M, et al: A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure.
N Engl J Med 339:429, 1998.
[PubMed: 9700176]
192. Antonelli M, Conti G, Moro ML, et al: Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med 1718:28, 2001.
193. Brower RG: Mechanical ventilation in acute lung injury and ARDS.
Crit Care Clin 18:1, 2002.
[PubMed: 11910724]
194. Suter PM, Fairley B, Isenberg MD: Optimum end-expiratory airway pressure in patients with acute pulmonary failure.
N Engl J Med 292:284, 1975.
[PubMed: 234174]
195. Dantzker DR, Brook CJ, Dehart P, et al: Ventilation-perfusion distributions in the adult respiratory distress syndrome.
Am Rev Respir Dis 120:1039, 1979.
[PubMed: 389116]
196. Lemaire F, Harf A, Teisseire BP:
Oxygen exchange across the acutely injured lung, in Zapol WM, Falke KJ (eds):
Acute Respiratory Failure. New York, Marcel Dekker, 1985, p 521.
197. Selecky PA, Wasserman K, Klein M, Ziment I: A graphic approach to assessing interrelationships among minute ventilation, arterial carbon dioxide tension, and ratio of physiologic dead space to tidal volume in patients on respirators.
Am Rev Respir Dis 117:181, 1978.
[PubMed: 619719]
198. Webb HH, Tierney DF: Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: Protection by positive end-expiratory pressure.
Am Rev Respir Dis 110:556, 1974.
[PubMed: 4611290]
199. Dreyfuss D, Basset G, Soler P, Saumon G: Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats.
Am Rev Respir Dis 132:880, 1985.
[PubMed: 3901844]
200. Dreyfuss D, Soler P, Basset G, Saumon G: High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure.
Am Rev Respir Dis 137:1159, 1988.
[PubMed: 3057957]
201. Kolobow T, Moretti MP, Fumagalli R, et al: Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study.
Am Rev Respir Dis 135:312, 1987.
[PubMed: 3544984]
202. Hernandez LA, Peevy KJ, Moise AA, et al: Chest wall restrictions limit high airway pressure induced lung injury in young rabbits.
J Appl Physiol 66:2364, 1989.
[PubMed: 2745302]
203. Carlton DP, Cummings JJ, Scheerer RG, et al: Lung overexpansion increases pulmonary microvascular protein permeability in young lambs. J Appl Physiol 69:557, 1990.
204. Corbridge
TC, Wood LD, Crawford GP, et al: Adverse effects of large tidal volume and low PEEP in canine acid aspiration.
Am J Respir Crit Care Med 142:311, 1990.
[PubMed: 2200314]
205. Mandava S, Kolobow T, Vitale G, et al: Lethal systemic capillary leak syndrome associated with severe ventilator-induced lung injury: an experimental study.
Crit Care Med 31:885, 2003.
[PubMed: 12627001]
206. Imai Y, Parodo J, Kajikawa O, et al: Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome [see comment].
JAMA 289:2104, 2003.
[PubMed: 12709468]
207. Tremblay LN, Miatto D, Hamid Q, et al: Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA [see comment].
Crit Care Med 30:1693, 2002.
[PubMed: 12163778]
208. Zhang H, Downey GP, Suter PM, et al: Conventional mechanical ventilation is associated with bronchoalveolar lavage-induced activation of polymorphonuclear leukocytes: a possible mechanism to explain the systemic consequences of ventilator-induced lung injury in patients with ARDS.
Anesthesiology 97:1426, 2002.
[PubMed: 12459668]
209. Maunder RJ, Shuman WP, McHugh JW, et al: Preservation of normal lung regions in the adult respiratory distress syndrome.
JAMA 255:2463, 1986.
[PubMed: 3701964]
210. Roupie E, Dambrosio M, Servillo G, et al: Titration of tidal volume and induced hypercapnea in acute respiratory distress syndrome.
Am J Respir Crit Care Med 152:121, 1995.
[PubMed: 7599810]
211. Holzapfel L, Robert D, Perrin F, et al: Static pressure-volume curves and effect of positive end-expiratory pressure on gas exchange in adult respiratory distress syndrome.
Crit Care Med 11:591, 1983.
[PubMed: 6409503]
212. Crotti S, Mascheroni D, Caironi P, et al: Recruitment and derecruitment during acute respiratory failure: a clinical study.
Am J Respir Crit Care Med 164:131, 2001.
[PubMed: 11435251]
213. Pelosi P, Goldner M, Mckibben A, et al: Recruitment and derecruitment during acute respiratory failure. An experimental study.
Am J Respir Crit Care Med 164:122, 2001.
[PubMed: 11435250]
214. Hickling KG: Best compliance during a decremental, but not incremental, positive end-expiratory pressure trial is related to open-lung positive end-expiratory pressure: a mathematical model of acute respiratory distress syndrome lungs.
Am J Respir Crit Care Med 163:69, 2001.
[PubMed: 11208628]
215. Eichacker PQ, Gerstenberger EP, Banks SM, et al: Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes [see comment].
Am J Respir Crit Care Med 166:1510, 2002.
[PubMed: 12406836]
216. Steinbrook R: How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome [comment].
N Engl J Med 348:1393, 2003.
[PubMed: 12672870]
217. Steinbrook R: Trial design and patient safety—the debate continues [comment].
N Engl J Med 349:629, 2003.
[PubMed: 12917298]
218. Gattinoni L PP, Crotti S, et al: Effects of positive end-expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome.
Am J Respir Crit Care Med 151:1807, 1995.
[PubMed: 7767524]
219. Amato MB, Barbas CS, Medeiros DM, et al: Beneficial effects of the “open lung approach" with low distending pressures in acute respiratory distress syndrome.
Am J Respir Crit Care Med 152:1835, 1995.
[PubMed: 8520744]
220. Shoemaker WC: Goal-oriented hemodynamic therapy.
N Engl J Med 334:799, 1996.
[PubMed: 8592562]
221. Boyd O, Grounds RM, Bennett ED: A randomized clinical trial of the effect of deliberate perioperative increase of
oxygen delivery on mortality in high-risk surgical patients.
JAMA 270:2699, 1993.
[PubMed: 7907668]
222. Ronco JJ, Fenwick JC, Tweeddale MG, et al: Identification of the critical
oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans.
JAMA 270:1724, 1993.
[PubMed: 8411504]
223. Ronco JJ, Phang PT, Walley KR, et al:
Oxygen consumption is independent of changes in
oxygen delivery in severe adult respiratory distress syndrome.
Am J Respir Crit Care Med 143:1267, 1991.
[PubMed: 2048811]
224. Gattinoni L, Brazzi L, Pelosi P, et al: The SvO2 Collaborative Group. A trial of goal-oriented hemodynamic therapy in critically ill patients.
N Engl J Med 333:1025, 1995.
[PubMed: 7675044]
225. Hayes MA, Timmins
AC, Yau E, et al: Elevation of systemic
oxygen delivery in the treatment of critically ill patients.
N Engl J Med 330:1717, 1994.
[PubMed: 7993413]
226. Prewitt RM, McCarthy J, Wood LDH: Treatment of acute low pressure edema in dogs: Relative effects of hydrostatic and oncotic pressure,
nitroprusside, and positive end expiratory pressure.
J Clin Invest 67:409, 1981.
[PubMed: 7007436]
227. Long GR, Breen PH, Mayers I, Wood LD: Treatment of canine aspiration pneumonitis: Fluid volume reduction vs. fluid volume expansion.
J Appl Physiol 65:1736, 1988.
[PubMed: 3182534]
228. Sznajder JI, Zucker AR, Wood LD, Long GR: Effects of plasmapheresis and hemofiltration on acid aspiration pulmonary edema.
Am J Respir Crit Care Med 134:222, 1986.
[PubMed: 3740647]
229. Gottlieb SS, Wood LD, Hansen DE, Long GR: The effect of
nitroprusside on pulmonary edema,
oxygen exchange, and blood flow in hydrochloric acid aspiration.
Anesthesiology 67:47, 1987.
230. Zucker AR, Becker CJ, Berger S, et al: Pathophysiology of treatment of canine kerosene pulmonary injury: The effects of plasmapheresis and positive end-expiratory pressure on canine kerosene pulmonary injury. J Crit Care 4:184, 1989.
231. Oppenheimer L, Wood LD, Prewitt RM: Acute effects of
nitroprusside in patients with hypoxemic respiratory failure.
Surg Forum 32:306, 1981.
232. Zucker AR, Wood LD, Curet-Scott M, et al: Partial lung bypass reduces kerosene lung injury in dogs. J Crit Care 6:29, 1991.
234. Mitchel JP, Schuller D, Calandrino FS, et al: Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am J Respir Crit Care Med 145:990, 1992.
235. Simmons RS, Berdine GG, Seidenfeld JJ, et al: Fluid balance and the adult respiratory distress syndrome.
Am J Respir Crit Care Med 135:924, 1987.
[PubMed: 3565940]
236. Humphrey H, Hall J, Sznajder I, et al: Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure.
Chest 97:1176, 1990.
[PubMed: 2100979]
237. Eisenberg PR, Hansbrough JR, Anderson D, Schuster DP: A prospective study of lung water measurements during patient management in an intensive care unit.
Am J Respir Crit Care Med 136:662, 1987.
[PubMed: 3307570]
239. Hudson LD: Fluid management strategy in acute lung injury.
Am J Respir Crit Care Med 145:988, 1992.
[PubMed: 1524595]
240. O'Quinn R, Marini JJ. Pulmonary artery occlusion pressure: Clinical physiology, measurement, and interpretation.
Am J Respir Crit Care Med 128:319, 1983.
[PubMed: 16548052]
241. Teboul JL, Besbes M, Andrivet P, et al: A bedside index assessing the reliability of pulmonary artery occlusion pressure measurements during mechanical ventilation with positive end-expiratory pressure. J Crit Care 7:22, 1992.
242. Rizvi K, de Boisblanc B, Dhillon G, Arroliga A, the NIH/NHLBI ARDS Network. Effect of airway pressure display on inter-observer variability in assessment of vascular pressure in the ARDSnet Fluids and Catheters Treatment Trial (FACTT). Am J Respir Crit Care Med 167:A617, 2003.
243. Pinsky M, Vincent JL, De Smet JM: Estimating left ventricular filling pressure during positive end-expiratory pressure in humans.
Am J Respir Crit Care Med 143:25, 1991.
[PubMed: 1986680]
244. Carter RS, Snyder JV, Pinsky MR: LV filling pressure during PEEP measured by nadir wedge pressure after airway disconnection. Am J Physiol 249:H770, 1985.
245. Hickling KG, Henderson S, Jackson R: Low mortality associated with low volume pressure limited ventilation with permissive hypercapnea in severe adult respiratory distress syndrome.
Intensive Care Med 16:372, 1990.
[PubMed: 2246418]
246. Hickling KG, Walsh J, Henderson S, Jackson R: Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnea: A prospective study.
Crit Care Med 22:1568, 1994.
[PubMed: 7924367]
247. Feihl F, Perret C: Permissive hypercapnia: How permissive should we be?
Am J Respir Crit Care Med 150:1722, 1994.
[PubMed: 7952641]
248. Tuxen DV: Permissive hypercapnic ventilation.
Am J Respir Crit Care Med 150:870, 1994.
[PubMed: 8087364]
249. Langer M, Mascheroni D, Marcolin R, Gattinoni L: The prone position in ARDS patients: A clinical study.
Chest 94:103, 1988.
[PubMed: 3383620]
250. Pappert D, Rossaint R, Slama K, et al: Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome.
Chest 106:1511, 1994.
[PubMed: 7956412]
251. Douglas W, Rehder K, Beynen RM, et al: Improved oxygenation in patients with acute respiratory failure.
Am J Respir Crit Care Med 115:559, 1977.
[PubMed: 322557]
252. Gattinoni L, Tognoni G, Pesenti A, et al: Effect of prone positioning on the survival of patients with acute respiratory failure.
N Engl J Med 345:568, 2001.
[PubMed: 11529210]
253. Lamm WJ, Graham MM, Albert RK: Mechanism by which the prone position improves oxygenation in acute lung injury.
Am J Respir Crit Care Med 150:184, 1994.
[PubMed: 8025748]
254. Pelosi P, Croci M, Calappi E, et al: The prone positioning during general anesthesia minimally affects respiratory mechanics while improving functional residual capacity and increasing
oxygen tension.
Anesth Analg 80:955, 1995.
[PubMed: 7726438]
255. Glenny RW, Lamm WJ, Albert RK, Robertson HT: Gravity is a minor determinant of pulmonary blood flow distribution.
J Appl Physiol 71:620, 1991.
[PubMed: 1938736]
256. Gattinoni L, Pelosi P, Vitale G, et al: Body position changes redistribute lung computed-tomography density in patients with acute respiratory failure.
Anesthesiology 74:15, 1991.
[PubMed: 1986640]
257. Gattinoni L, Vagginelli F, Carlesso E, et al: Prone-Supine Study G. Decrease in PaCO2 with prone position is predictive of improved outcome in acute respiratory distress syndrome [see comment].
Crit Care Med 31:2727, 2003.
[PubMed: 14668608]
258. Pelosi P, Bottino N, Chiumello D, et al: Sigh in supine and prone position during acute respiratory distress syndrome.
Am J Respir Crit Care Med 167:521, 2003.
[PubMed: 12493644]
259. Marini JJ, Gattinoni L: Ventilatory management of acute respiratory distress syndrome: a consensus of two.
Crit Care Med 32:250, 2004.
[PubMed: 14707588]
260. The ARDS Clinical Trials Network NHLBI, National Institutes of Health. Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure. Crit Care Med 31:2592, 2003.
261. Foti G, Cereda M, Sparacino ME, et al: Effects of periodic lung recruitment maneuvers on gas exchange and respiratory mechanics in mechanically ventilated acute respiratory distress syndrome (ARDS) patients [see comment].
Intensive Care Med 26:501, 2000.
[PubMed: 10923722]
262. Van der Kloot, Thomas E, Blanch L, et al: Recruitment maneuvers in three experimental models of acute lung injury. Effect on lung volume and gas exchange. Am J Respir Crit Care Med 161:1485, 2000.
263. Villagra A, Ochagavia A, Vatua S, et al: Recruitment maneuvers during lung protective ventilation in acute respiratory distress syndrome.
Am J Respir Crit Care Med 165:165, 2002.
[PubMed: 11790648]
264. Richard J-C, Maggiore SM, Jonson B, et al: Influence of tidal volume on alveolar recruitment. Respective role of PEEP and a recruitment maneuver.
Am J Respir Crit Care Med 163:1609, 2001.
[PubMed: 11401882]
265. Lim CM, Koh Y, Park W, et al: Mechanistic scheme and effect of “extended sigh" as a recruitment maneuver in patients with acute respiratory distress syndrome: a preliminary study.
Crit Care Med 29:1255, 2001.
[PubMed: 11395617]
266. Pelosi P, Bottino N, Chiumello D, et al: Sigh in supine and prone position during acute respiratory distress syndrome.
Am J Respir Crit Care Med 167:521, 2003.
[PubMed: 12493644]
267. Pelosi P, Cadringher P, Bottino N, et al: Sigh in acute respiratory distress syndrome.
Am J Respir Crit Care Med 159:872, 1999.
[PubMed: 10051265]
268. Patroniti N, Foti G, Cortinovis B, et al: Sigh improves gas exchange and lung volume in patients with acute respiratory distress syndrome undergoing pressure support ventilation [see comment].
Anesthesiology 96:788, 2002.
[PubMed: 11964584]
269. Hadorn DC: Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue [see comment].
JAMA 265:2218, 1991.
[PubMed: 1901610]
270. Carter C, Adams AB, Stone M, et al: Tracheal gas insufflation during late exhalation efficiently reduces PaCO(2) in experimental acute lung injury.
Intensive Care Med 28:504, 2002.
[PubMed: 11967608]
271. Nahum A, Shapiro RS, Ravenscraft SA, et al: Efficacy of expiratory tracheal gas insufflation in a canine model of lung injury.
Am J Respir Crit Care Med 152:489, 1995.
[PubMed: 7633697]
272. Belghith M, Fierobe L, Brunet F, et al: Is tracheal gas insufflation an alternative to extrapulmonary gas exchangers in severe ARDS?
Chest 107:1416, 1995.
[PubMed: 7750341]
273. Roissant R, Falke KJ, Lopez F, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399, 1993.
274. Rossaint R, Gerlach H, Schmidt-Ruhnke H, et al: Efficacy of inhaled nitric oxide in patients with severe ARDS.
Chest 107:1107, 1995.
[PubMed: 7705124]
275. Bigatello LM, Hurford WE, Kacmarek RM, et al: Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome.
Anesthesiology 80:761, 1994.
[PubMed: 8024129]
276. Puybasset L, Stewart T, Rouby JJ, et al: Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnea in patients with adult respiratory distress syndrome.
Anesthesiology 80:1254, 1994.
[PubMed: 8010472]
277. Lowson SM, Rich GF, McArdle PA, et al: The response to varying concentrations of inhaled nitric oxide in patients with acute respiratory distress syndrome.
Anesth Analg 82:574, 1996.
[PubMed: 8623964]
278. Benzing A, Brautigam P, Geiger K, et al: Inhaled nitric oxide reduces pulmonary transvascular
albumin flux in patients with acute lung injury.
Anesthesiology 83:113, 1996.
279. Lavoie A, Hall JB, Olson DM, Wylam ME: Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med 1996.153:1985.
280. Taylor RW, Zimmerman JL, Dellinger RP, et al: Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial.
JAMA 291:1603, 2004.
[PubMed: 15069048]
281. Reily DJ, Tollok E, Mallitz K, et al: Successful aeromedical transport using inhaled prostacyclin for a patient with life-threatening hypoxemia.
Chest 125:1579, 2004.
[PubMed: 15078777]
282. Dahlem P, van Aalderen WM, de Neef M, et al: Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury [see comment].
Crit Care Med 32:1055, 2004.
[PubMed: 15071401]
283. Siobal MS, Kallet RH, Pittet JF, et al: Description and evaluation of a delivery system for aerosolized prostacyclin.
Respiratory Care. 48:742, 2003.
[PubMed: 12890294]
284. Lowson SM: Inhaled alternatives to nitric oxide [see comment].
Anesthesiology 96:1504, 2002.
[PubMed: 12170067]
285. Bernard GR, Luce JM, Sprung CL, et al: High-dose corticosteroids in patients with adult respiratory distress syndrome.
N Engl J Med 317:1565, 1987.
[PubMed: 3317054]
286. Bone RC, Fisher CJ Jr, Clemmer TP, et al: Ineffectiveness of high-dose
methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock.
Chest 92:1032, 1987.
[PubMed: 3315478]
287. Meduri GU, Chinn AJ, Leeper KV, et al: Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome.
Chest 105:1516, 1994.
[PubMed: 8181346]
288. Hooper RG, Kearl RA: Established ARDS treated with a sustained course of adrenocortical steroids.
Chest 97:138, 1990.
[PubMed: 2295233]
289. Ashbaugh DG, Maier RV: Idiopathic pulmonary fibrosis in adult respiratory distress syndrome: Diagnosis and treatment.
Arch Surg 120:530, 1985.
[PubMed: 3885914]
290. Meduri GU, Tolley EA, Chrousos GP, Stentz F: Prolonged
methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids.
Am J Respir Crit Care Med 165:983, 2002.
[PubMed: 11934726]
291. Hudson L: Preliminary results from the NHLBI ARDS Clinical Trials Network's LaSRS trial. Presented at International Meeting of the American Thoracic Society. Orlando, FL. 2004.
292. Tharratt RS, Allen RP, Albertson TE: Pressure controlled inverse ratio ventilation in severe adult respiratory failure.
Chest 94:755, 1988.
[PubMed: 3168572]
293. Cole AG, Weller SF, Sykes MK: Inverse ratio ventilation compared with PEEP in adult respiratory failure.
Intensive Care Med 10:227, 1984.
[PubMed: 6386921]
294. Gurevitch MJ, Van Dyke J, Young ES, Jackson K: Improved oxygenation and lower peak airway pressure in severe adult respiratory distress syndrome: Treatment with inverse ratio ventilation.
Chest 89:211, 1986.
[PubMed: 3943380]
295. Manthous CA, Schmidt GA. IRV in ARDS: Improved oxygenation without autoPEEP. Chest 103:953, 1992.
296. Mercat A, Graini L, Teboul JL, et al: Cardiorespiratory effects of pressure-controlled ventilation with and without inverse ratio in the adult respiratory distress syndrome.
Chest 104:871, 1993.
[PubMed: 8365303]
297. Sydow M, Burchardi H, Ephraim E, et al: Long term effects of two different ventilatory modes on oxygenation in acute lung injury: Comparison of airway pressure release ventilation and volume-controlled inverse ratio ventilation.
Am J Respir Crit Care Med 149:1550, 1994.
[PubMed: 8004312]
298. Derdak S: High-frequency oscillatory ventilation for acute respiratory distress syndrome in adult patients. Crit Care Med 31:S317, 2003.
299. Derdak S, Mehta S, Stewart TE, et al: Multicenter Oscillatory Ventilation For Acute Respiratory Distress Syndrome Trial Study I. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: A randomized, controlled trial [see comment].
Am J Respir Crit Care Med 166:801, 2002.
[PubMed: 12231488]
300. Holzapfel L, Robert D, Perrin F, et al: Comparison of high frequency jet ventilation to conventional ventilation in adults with respiratory distress syndrome.
Intensive Care Med 13:100, 1987.
[PubMed: 3553269]
301. Carlon GC, Howland WS, Ray C, et al: High frequency jet ventilation: A prospective randomized evaluation.
Chest 84:551, 1983.
[PubMed: 6628006]
302. Schuster DP, Klain M, Snyder JV: Comparison of high frequency jet ventilation to conventional ventilation during severe acute respiratory failure in humans.
Crit Care Med 10:625, 1982.
[PubMed: 6749433]
303. Zobel G, Kuttnig-Haim M, Decar D, et al: Extracorporeal membrane oxygenation in severe acute respiratory failure. JAMA 242:2193, 1979.
304. Egan TM, Duffin J, Glynn MF, et al: Ten-year experience with extracorporeal membrane oxygenation for severe respiratory failure.
Chest 94:681, 1988.
[PubMed: 3168565]
305. Snider MTCampbell DB, Kofke WA, et al: Venovenous perfusion of adults and children with severe acute respiratory distress syndrome.
ASAIO 34:1014, 1988.
[PubMed: 3219247]
306. Gattinoni L, Pesenti A, Mascheroni D, et al: Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure.
JAMA 256:881, 1986.
[PubMed: 3090285]
307. Morris AH, Wallace CJ, Menlove RL, et al: Randomized clinical trial of pressure controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.
Am J Respir Crit Care Med 149:295, 1994.
[PubMed: 8306022]
308. Anderson H 3rd, Steimle C, Shapiro M, et al: Extracorporeal life support for adult cardiorespiratory failure.
Surgery 114:161, 1993.
[PubMed: 8342122]
309. Hirschl RB, Pranikoff T, Wise C, et al: Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome.
JAMA 275:383, 1996.
[PubMed: 8569018]
310. Spitzer AR, Lipsky CL: Partial liquid ventilation with Perflubron in premature infants with severe respiratory distress syndrome.
Clin Pediatr 36:181, 1997.
[PubMed: 9138892]
311. Pranikoff T, Gauger PG, Hirschl RB: Partial liquid ventilation in newborn patients with congenital diaphragmatic hernia.
J Pediatr Surg 31:613, 1996.
[PubMed: 8861466]
312. Leach CL, Greenspan JS, Rubenstein SD, et al: Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome: The LiquiVent Study Group.
N Engl J Med 335:761, 1996.
[PubMed: 8778584]
313. Hirschl RB, Croce M, Gore D, et al: Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome.
Am J Respir Crit Care Med 165:781, 2002.
[PubMed: 11897644]
314. Hallman M, Spragg R, Harrell JH, et al: Evidence of lung surfactant abnormality in respiratory failure.
J Clin Invest 70:673, 1982.
[PubMed: 6896715]
315. Lewis JF, Jobe AH: Surfactant and the adult respiratory distress syndrome.
Am Rev Resp Dis 147:218, 1993.
[PubMed: 8420422]
316. Jobe A, Ikegami M: Surfactant for the treatment of respiratory distress syndrome.
Am J Respir Crit Care Med 136:1256, 1987.
[PubMed: 3314618]
317. Merritt TA, Hallman M, Bloom BT, et al: Prophylactic treatment of very premature infants with human surfactant.
N Engl J Med 315:785, 1986.
[PubMed: 3528853]
318. Horbar JD, Soll RF, Sutherland JM, et al: A multicenter, randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
N Engl J Med 320:959, 1989.
[PubMed: 2648150]
319. Spragg RG, Lewis JF, Wurst W, et al: Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant.
Am J Respir Crit Care Med 167:1562, 2003.
[PubMed: 12649125]
320. Spragg RG, Rathgeb F, Hafner D, et al: Intratracheal instillation of rSP-C surfactant improves oxygenation in patients with ARDS (Abstract). Am J Respir Crit Care Med 165:A22, 2002.
321. Seeger W, Hafner D, Lewis JF, et al: Treatment with rSP-C surfactant reduces mortality in ARDS due to primary pulmonary events (Abstract). Am J Respir Crit Care Med 165:A219, 2002.
322. Gregory TJ, Steinberg KP, Spragg R, et al: Bovine surfactant therapy for patients with acute respiratory distress syndrome.
Am J Respir Crit Care Med 155:1309, 1997.
[PubMed: 9105072]
323. Spragg RG, Lewis JF, Walmrath H-D, Johannigman J, et al: Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.
N Engl J Med 351:884, 2004.
[PubMed: 15329426]
324. Milberg JA, Davis DR, Steinberg KP, Hudson LD: Improved survival of patients with acute respiratory distress syndrome (ARDS).
JAMA 273:306, 1995.
[PubMed: 7815658]
325. McHugh L, Milberg J, Whitcomb M, et al: Recovery of function in survivors of the acute respiratory distress syndrome.
Am J Respir Crit Care Med 150:90, 1994.
[PubMed: 8025779]
326. Orme J Jr, Romney JS, Hopkins RO, et al: Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome.
Am J Respir Crit Care Med 167:690, 2003.
[PubMed: 12493646]
327. Weinert CR, Gross CR, Kangas JR, et al: Health-related quality of life after acute lung injury.
Am J Respir Crit Care Med 156:1120, 1997.
[PubMed: 9351611]
328. Schelling G, Stoll C, Haller M, et al: Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome.
Crit Care Med 26:651, 1998.
[PubMed: 9559601]
329. Angus DC, Musthafa AA, Clermont G: Quality-adjusted survival in the first year after the acute respiratory distress syndrome.
Am J Respir Crit Care Med 163:1389, 2001.
[PubMed: 11371406]
330. Hopkins R, Weaver L, Pope D, et al: Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome.
Am J Respir Crit Care Med 160:50, 1999.
[PubMed: 10390379]
331. Moss M, Parsons PE, Steinberg KP, et al: Chronic
alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock.
Crit Care Med 31:869, 2003.
[PubMed: 12626999]
332. Moss M, Burnham EL: Chronic
alcohol abuse, acute respiratory distress syndrome, and multiple organ dysfunction.
Crit Care Med 31:S207, 2003.
333. Collins FS, Green ED, Guttmacher AE, Guyer MS: A vision for the future of genomics research.
Nature 422:835, 2003.
[PubMed: 12695777]
334. Rubenfeld GD, Cooper C, Carter G, et al: Barriers to providing lung-protective ventilation to patients with acute lung injury.
Crit Care Med 32:1289, 2004.
[PubMed: 15187508]
335. Young MP, Manning HL, Wilson DL, et al: Ventilation of patients with acute lung injury and acute respiratory distress syndrome: has new evidence changed clinical practice? [see comment].
Crit Care Med 32:1260, 2004.
[PubMed: 15187503]
336. Weinert CR, Gross CR, Marinelli WA: Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals [see comment].
Am J Respir Crit Care Med 167:1304, 2003.
[PubMed: 12574072]
337. Stewart TE: Effective ventilation strategies for acute respiratory distress syndrome.
Can Respir J 10:171, 2003.
[PubMed: 12712231]